• TrialX, ALS Network Partnership, Novel Multi-Cancer Detection Blood Test, More

    Clinical Research News | TrialX has joined a partnership with the ALS Network; Fred Hutch Cancer Center has launched the Vanguard Study, a national study of a new type of blood test that screens several different cancers called multi-cancer detection (MCD) tests; and more.

    Jul 31, 2025

  • Follow the Money: Platform Creates Detailed Tumor Profiles, AI Helps with Clinical Trial Benchmarking, More

    Clinical Research News | One Biosciences will further develop its OneMap platform, which creates detailed functional profiles of patient tumors that may help with optimizing clinical trials; Argon AI plans to expand their to build customized AI agents that can automate tasks, including clinical trial benchmarking; and more.

    Jul 30, 2025

  • The Connectivity Factor: How Interoperability, via AI Agents, Speeds Precision Medicine

    Clinical Research News | What if trial timelines could be cut by years—just by improving how R&D systems and ecosystems talk to each other? In a recent study using generative AI (GAI) to aid decision-making from an integrated data ecosystem, trials sped up by more than 12 months.

    Jul 25, 2025

  • AI-Powered Cell Mapping Could Transform Precision Oncology and Accelerate Clinical Trials

    Clinical Research News | Scientists at Virginia Commonwealth University (VCU) are tackling the massive computational problem of determining the distinct types of cells inhabiting biopsied tissue. Their endgame is to deploy a suite of interoperable artificial intelligence (AI) tools that can accurately and reliably guide prescribing decisions for patients with cancer as well as predict their response to investigational treatments prior to enrollment.

    Jul 22, 2025

  • How ‘Living’ Datasets Will Shape the Future of Precision Medicine

    Clinical Research News | Imagine trying to piece together a puzzle with half the pieces missing—that’s what happens when data is siloed. Without integrated, centralized data across sources, data decisions are made using incomplete, fragmented datasets.

    Jul 18, 2025

  • New Kind of Trial Tests Multiomics-Based Therapy Predictions

    Clinical Research News | As gastrointestinal (GI) trials grow more sophisticated, the volume, velocity, and variety of study data have all expanded. One of the fastest-growing streams is electronic patient-reported outcomes (ePROs): diaries, symptom scores, quality-of-life surveys, and other instruments that come straight from the participant. Collecting this data quickly and conveniently is now mission critical.

    Jul 17, 2025

  • Novel Blood Test Offers Early Cancer Treatment Response Monitoring in Clinical Trials

    Clinical Research News | A fragmentation-based blood test is providing pharmaceutical companies with a new way to monitor cancer treatment response in clinical trials, informing how drug efficacy is evaluated in early-stage development. Delfi Diagnostics has developed DELFI-TF (DELFI-tumor fraction), a research-grade assay that uses a unique fragmentation approach to detect circulating tumor DNA in blood samples.

    Jul 15, 2025